Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
5-HT(6) receptor and cognition.
Codony X, Vela JM, Ramírez MJ. Codony X, et al. Among authors: vela jm. Curr Opin Pharmacol. 2011 Feb;11(1):94-100. doi: 10.1016/j.coph.2011.01.004. Epub 2011 Feb 15. Curr Opin Pharmacol. 2011. PMID: 21330210 Review.
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
Romero L, Zamanillo D, Nadal X, Sánchez-Arroyos R, Rivera-Arconada I, Dordal A, Montero A, Muro A, Bura A, Segalés C, Laloya M, Hernández E, Portillo-Salido E, Escriche M, Codony X, Encina G, Burgueño J, Merlos M, Baeyens JM, Giraldo J, López-García JA, Maldonado R, Plata-Salamán CR, Vela JM. Romero L, et al. Among authors: vela jm. Br J Pharmacol. 2012 Aug;166(8):2289-306. doi: 10.1111/j.1476-5381.2012.01942.x. Br J Pharmacol. 2012. PMID: 22404321 Free PMC article.
5-HT6 receptor signal transduction second messenger systems.
Codony X, Burgueño J, Ramírez MJ, Vela JM. Codony X, et al. Among authors: vela jm. Int Rev Neurobiol. 2010;94:89-110. doi: 10.1016/B978-0-12-384976-2.00004-6. Int Rev Neurobiol. 2010. PMID: 21081203 Review. No abstract available.
Sigma 1 receptor: a new therapeutic target for pain.
Zamanillo D, Romero L, Merlos M, Vela JM. Zamanillo D, et al. Among authors: vela jm. Eur J Pharmacol. 2013 Sep 15;716(1-3):78-93. doi: 10.1016/j.ejphar.2013.01.068. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23500210 Review.
Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.
Vidal-Torres A, de la Puente B, Rocasalbas M, Touriño C, Bura SA, Fernández-Pastor B, Romero L, Codony X, Zamanillo D, Buschmann H, Merlos M, Baeyens JM, Maldonado R, Vela JM. Vidal-Torres A, et al. Among authors: vela jm. Eur J Pharmacol. 2013 Jul 5;711(1-3):63-72. doi: 10.1016/j.ejphar.2013.04.018. Epub 2013 Apr 28. Eur J Pharmacol. 2013. PMID: 23632394
Sigma-1 Receptor and Pain.
Merlos M, Romero L, Zamanillo D, Plata-Salamán C, Vela JM. Merlos M, et al. Among authors: vela jm. Handb Exp Pharmacol. 2017;244:131-161. doi: 10.1007/164_2017_9. Handb Exp Pharmacol. 2017. PMID: 28275913 Review.
125 results